Organization · Corporate Venture Capital
Hikma Ventures
Hikma Ventures is the corporate venture capital arm of Hikma Pharmaceuticals, based in London. It focuses on investing in innovative digital health and life sciences companies globally, leveraging Hikma's pharmaceutical expertise.
Overview
What Hikma Ventures does
What Hikma Ventures is
Hikma Ventures is the corporate venture capital arm of Hikma Pharmaceuticals, based in London. It focuses on investing in innovative digital health and life sciences companies globally, leveraging Hikma's pharmaceutical expertise.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find Hikma Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Hikma Ventures as a funder
Investment thesis
Hikma Ventures invests in disruptive technologies and meaningful companies where there is a strategic advantage for both Hikma and the portfolio company, focusing on digital health and life sciences.
Focus narrative
Hikma Ventures invests in disruptive technologies within the digital health and life sciences sectors. Its investment areas include Drug Delivery, Digital Therapeutics, Clinical Trial Innovation, and solutions for chronic diseases such as Type II Diabetes and hypertension. The organization is stage-agnostic but prefers investments at Series A and beyond, with an average investment size of up to $5 million per company per round.
Value beyond capital
Hikma Ventures adds value to its portfolio companies by leveraging Hikma Pharmaceuticals' expertise and global reach, facilitating strategic partnerships, enhancing product differentiation, and accelerating market access. The fund's long-term view and focus on healthcare technology enable it to support companies in navigating the complexities of the healthcare landscape.
Terms and economics
- Typical check
- $1,000,000–$5,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Growth Equity
- Regions
- Global · Uk
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 20
- Recorded notable exits
- Lemonaid Health, Nebula Genomics, Propeller Health, Pillo, Tact.ai, and Winterlight
Portfolio context
Notable portfolio companies include: Activ Surgical: Surgical intelligence and intraoperative visualization company. Altibbi: Digital health platform serving Arabic-speaking patients. Altoida: Neurological disease assessment and brain-health technology company. Biolinq: Metabolic health and biosensing company, recognized as one of TIME's 10 Most Influential Health & Life Sciences Companies of 2026. Click Therapeutics: Digital therapeutics company with FDA-authorized migraine treatment. Lemonaid Health: Telehealth company acquired by 23andMe. Nebula Genomics: Genomics company acquired by ProPhase Labs. NuvoAir: Respiratory health and virtual-care platform. Propeller Health: Respiratory digital health company acquired by ResMed. Octave: Precision care and diagnostics company focused on neurodegenerative and autoimmune conditions.
Common questions
What to know about Hikma Ventures
Upseed classifies Hikma Ventures under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.